• By Deepti Babu, MS, CGC
  • Posted May 17, 2017

Lynch Syndrome - It's more common than you think

Did you know that more than 1 in 4 of those with Lynch syndrome (LS) are missed by current genetic testing guidelines? New research from Ambry Genetics and Ohio State University of nearly 35,000 patients will change how the genetics community thinks about genetic testing strategies, lifetime cancer risks, and medical management for people with …


  • By Jackie Connor
  • Posted May 8, 2017

Mauli Ola Foundation’s Surf Experience Day Tour Kicks Off in Honolulu

Cystic fibrosis (CF) is a progressive genetic disease that causes chronic lung infections and, over time, limits a person’s ability to breathe. More than 30,000 people in the United States are living with CF and about 1,000 new cases of CF are diagnosed every year. In 2006, a group of researchers based in Australia noticed that people who have …


  • By Stephany Tandy-Connor, MS, CGC
  • Posted May 4, 2017

Direct-to-Consumer Genetic Testing: Taking the Trend to the Next Level…Responsibly

Our DNA tells a story — it tells us who we are. With advancements in genetic testing and an increased awareness in personalized healthcare, interest in direct-to-consumer (DTC) testing is on the rise. DTC genetic testing companies have made limited genetic testing for the general population readily accessible to healthy individuals. However, …


  • By Deepti Babu, MS, CGC
  • Posted April 24, 2017

Piece by Piece: Exome Sequencing Helps Solve the Autism Puzzle

Autism spectrum disorders (ASDs) are neurodevelopmental disorders (NDDs) seen in 1-2% of children; symptoms and severity differ widely1,2,3, so they can be difficult to diagnose. ASDs can be inherited and involve numerous genes, which creates a challenge for single gene testing. How can genetic testing help children and families, if the child …


  • By Jackie Connor
  • Posted April 17, 2017

AmbryShare Extends Cohort Invite to Autism Clinicians and their Patients

Accurate genetic testing can help clinicians provide more individualized treatments for their patients, and the more genetic information a researcher has access to, the more targeted treatments can be developed. {Read: “For Your Breast Cancer Practice: Data From More Than 60,000 Refines Predisposition Gene Risks”} In March 2016, Ambry’s …


  • By Deepti Babu, MS, CGC
  • Posted April 14, 2017

Ambry Genetics and Leading Academic Researchers Collaborate to Improve Knowledge of Genetic Risk Factors for Breast Cancer

New clinical evidence collected from >65,000 women with breast cancer demonstrates 83% of positive test results are found in genes that impact clinical management Multi-gene germline genetic testing allows for efficient analysis, maximizing risk assessment while minimizing the time needed for results. This has been particularly effective …


  • By Deepti Babu, MS, CGC
  • Posted April 10, 2017

Can Patients with Hematological Cancer Have Genetic Testing?

The short answer is: Genetic testing is possible, but depends on other factors. The question of whether genetic testing is possible for patients with a history of hematological cancer comes up often in the clinical setting and in the testing laboratory. This makes sense since genetic testing is performed on DNA isolated from white blood cells …


  • By Deepti Babu, MS, CGC
  • Posted April 3, 2017

Current Genetic Testing Guidelines Miss Some Families with CDH1 Mutations

Hereditary diffuse gastric cancer (HDGC) is an inherited cancer syndrome caused by CDH1 gene mutations. It occurs most frequently in Japan and eastern Asia; current incidence in the U.S. is estimated at 10-40 individuals per 100,000.1 Individuals with mutations in the CDH1 gene have up to an 80% lifetime risk of diffuse gastric …


  • By Jackie Connor
  • Posted March 31, 2017

Ambry Experts Provide Insight on Genetic Testing’s Clinical Utility at the 2017 SSO Annual Cancer Symposium

Ambry has continued to provide clinicians with the most relevant and useful information to encourage education about the benefits of genetic testing for patients and ways to streamline genetic testing in clinical practice. At the 2017 SSO Annual Cancer Symposium, Ambry hosted the presentation “On the Cutting Edge: Sharpening Your Genetic Awareness …


  • By Jackie Connor
  • Posted March 30, 2017

Ambry Talks Plans for Personalized Genomic Test Launch, Third Annual Trivia Night a Hit

On Thursday evening, March 23rd, an audience of more than 100 genetic counselors and geneticists from across the United States listened to Ambry Genetics’ Clinical Genomics Marketing Manager Layla Shahmirzadi, MS, CGC, discuss plans to launch a personalized genomic test for healthy individuals.  The talk took place at Events on Jackson venue …